Prefilled Syringe Use Growing Across A Range Of Therapeutic Segments
Improved patient compliance, efficient delivery of high-priced biologicals, and patient & caregiver safety are key market drivers in this sector. The cost of biologicals such as recombinant proteins has created interest in prefilled syringes to reduce cost and waste associated with the handling of vial-packaged drugs. Partnerships between device designers and drug developers are an essential element in the success of prefilled devices, particularly for patient self-administration.
These findings are contained in a new and comprehensive report: Prefilled Syringes: Drugs, Devices and Disease Therapeutics. The report analyzes eleven important prefilled syringe therapeutic segments including chronic diseases such as diabetes, autoimmune disorders, and hormone replacement, as well as drugs for oncology, blood factors, reproductive health, wellness programs and vaccine administration.
About Greystone
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
Greystone Associates
Utiliza seringa preumplutã în creºtere peste o serie de segmente terapeutice - Prefilled Syringe Use Growing Across A Range Of Therapeutic Segments - articole medicale engleza - startsanatate